nodes	percent_of_prediction	percent_of_DWPC	metapath
Dactinomycin—ocular cancer—head and neck cancer	0.166	0.26	CtDrD
Dactinomycin—ABCC6—Vinblastine—head and neck cancer	0.139	0.489	CbGbCtD
Dactinomycin—melanoma—head and neck cancer	0.0951	0.149	CtDrD
Dactinomycin—skin cancer—head and neck cancer	0.0884	0.138	CtDrD
Dactinomycin—muscle cancer—head and neck cancer	0.0824	0.129	CtDrD
Dactinomycin—germ cell cancer—head and neck cancer	0.0741	0.116	CtDrD
Dactinomycin—peripheral nervous system neoplasm—head and neck cancer	0.0683	0.107	CtDrD
Dactinomycin—sarcoma—head and neck cancer	0.0657	0.103	CtDrD
Dactinomycin—ABCC1—Vinblastine—head and neck cancer	0.0409	0.144	CbGbCtD
Dactinomycin—ABCC1—Docetaxel—head and neck cancer	0.0337	0.119	CbGbCtD
Dactinomycin—ABCG2—Fluorouracil—head and neck cancer	0.0295	0.104	CbGbCtD
Dactinomycin—ABCG2—Docetaxel—head and neck cancer	0.0225	0.0796	CbGbCtD
Dactinomycin—Reticulocytopenia—Hydroxyurea—head and neck cancer	0.0179	0.233	CcSEcCtD
Dactinomycin—ABCB1—Vinblastine—head and neck cancer	0.00986	0.0348	CbGbCtD
Dactinomycin—ABCB1—Docetaxel—head and neck cancer	0.00813	0.0287	CbGbCtD
Dactinomycin—Radiation injury—Hydroxyurea—head and neck cancer	0.0059	0.0768	CcSEcCtD
Dactinomycin—Recall phenomenon—Hydroxyurea—head and neck cancer	0.00357	0.0465	CcSEcCtD
Dactinomycin—Neutropenic sepsis—Fluorouracil—head and neck cancer	0.00257	0.0334	CcSEcCtD
Dactinomycin—Radiation recall reaction (dermatologic)—Docetaxel—head and neck cancer	0.00196	0.0255	CcSEcCtD
Dactinomycin—Recall phenomenon—Docetaxel—head and neck cancer	0.00185	0.0241	CcSEcCtD
Dactinomycin—Neutropenic sepsis—Docetaxel—head and neck cancer	0.00185	0.0241	CcSEcCtD
Dactinomycin—Proctitis—Fluorouracil—head and neck cancer	0.00183	0.0238	CcSEcCtD
Dactinomycin—Myelosuppression—Vinblastine—head and neck cancer	0.00145	0.0188	CcSEcCtD
Dactinomycin—Myelosuppression—Hydroxyurea—head and neck cancer	0.00132	0.0172	CcSEcCtD
Dactinomycin—Febrile neutropenia—Hydroxyurea—head and neck cancer	0.00103	0.0134	CcSEcCtD
Dactinomycin—Eruption—Hydroxyurea—head and neck cancer	0.00101	0.0131	CcSEcCtD
Dactinomycin—Multi-organ failure—Docetaxel—head and neck cancer	0.000987	0.0128	CcSEcCtD
Dactinomycin—Myelosuppression—Fluorouracil—head and neck cancer	0.00095	0.0124	CcSEcCtD
Dactinomycin—Hepatotoxicity—Hydroxyurea—head and neck cancer	0.000802	0.0104	CcSEcCtD
Dactinomycin—Extravasation—Vinblastine—head and neck cancer	0.000778	0.0101	CcSEcCtD
Dactinomycin—Febrile neutropenia—Fluorouracil—head and neck cancer	0.000741	0.00964	CcSEcCtD
Dactinomycin—Ascites—Docetaxel—head and neck cancer	0.000708	0.00921	CcSEcCtD
Dactinomycin—Raised liver function tests—Docetaxel—head and neck cancer	0.000697	0.00907	CcSEcCtD
Dactinomycin—Myelosuppression—Docetaxel—head and neck cancer	0.000686	0.00893	CcSEcCtD
Dactinomycin—Ulcer—Hydroxyurea—head and neck cancer	0.000655	0.00852	CcSEcCtD
Dactinomycin—Phlebitis—Vinblastine—head and neck cancer	0.000572	0.00745	CcSEcCtD
Dactinomycin—Necrosis—Fluorouracil—head and neck cancer	0.000568	0.00739	CcSEcCtD
Dactinomycin—Febrile neutropenia—Docetaxel—head and neck cancer	0.000535	0.00696	CcSEcCtD
Dactinomycin—Eruption—Docetaxel—head and neck cancer	0.000523	0.00681	CcSEcCtD
Dactinomycin—Extravasation—Fluorouracil—head and neck cancer	0.000511	0.00665	CcSEcCtD
Dactinomycin—Hepatic failure—Hydroxyurea—head and neck cancer	0.0005	0.00651	CcSEcCtD
Dactinomycin—Ulcer—Fluorouracil—head and neck cancer	0.000471	0.00613	CcSEcCtD
Dactinomycin—Hepatotoxicity—Docetaxel—head and neck cancer	0.000417	0.00542	CcSEcCtD
Dactinomycin—Necrosis—Docetaxel—head and neck cancer	0.00041	0.00533	CcSEcCtD
Dactinomycin—Oesophagitis—Fluorouracil—head and neck cancer	0.000407	0.0053	CcSEcCtD
Dactinomycin—Pancytopenia—Vinblastine—head and neck cancer	0.000405	0.00527	CcSEcCtD
Dactinomycin—Sepsis—Fluorouracil—head and neck cancer	0.000387	0.00503	CcSEcCtD
Dactinomycin—Pancytopenia—Hydroxyurea—head and neck cancer	0.000369	0.0048	CcSEcCtD
Dactinomycin—Extravasation—Docetaxel—head and neck cancer	0.000369	0.0048	CcSEcCtD
Dactinomycin—Neutropenia—Hydroxyurea—head and neck cancer	0.000363	0.00473	CcSEcCtD
Dactinomycin—Agranulocytosis—Vinblastine—head and neck cancer	0.000354	0.00461	CcSEcCtD
Dactinomycin—Pharyngitis—Vinblastine—head and neck cancer	0.000338	0.0044	CcSEcCtD
Dactinomycin—Stomatitis—Hydroxyurea—head and neck cancer	0.000338	0.00439	CcSEcCtD
Dactinomycin—Lethargy—Fluorouracil—head and neck cancer	0.00033	0.0043	CcSEcCtD
Dactinomycin—Alopecia—Vinblastine—head and neck cancer	0.000301	0.00392	CcSEcCtD
Dactinomycin—Oesophagitis—Docetaxel—head and neck cancer	0.000294	0.00383	CcSEcCtD
Dactinomycin—Dysphagia—Fluorouracil—head and neck cancer	0.00028	0.00364	CcSEcCtD
Dactinomycin—Sepsis—Docetaxel—head and neck cancer	0.000279	0.00363	CcSEcCtD
Dactinomycin—Chills—Hydroxyurea—head and neck cancer	0.000279	0.00363	CcSEcCtD
Dactinomycin—Ill-defined disorder—Vinblastine—head and neck cancer	0.000275	0.00358	CcSEcCtD
Dactinomycin—Alopecia—Hydroxyurea—head and neck cancer	0.000275	0.00358	CcSEcCtD
Dactinomycin—Anaemia—Vinblastine—head and neck cancer	0.000274	0.00357	CcSEcCtD
Dactinomycin—Phlebitis—Docetaxel—head and neck cancer	0.000271	0.00353	CcSEcCtD
Dactinomycin—Erythema—Hydroxyurea—head and neck cancer	0.000271	0.00352	CcSEcCtD
Dactinomycin—Malaise—Vinblastine—head and neck cancer	0.000268	0.00348	CcSEcCtD
Dactinomycin—Leukopenia—Vinblastine—head and neck cancer	0.000266	0.00346	CcSEcCtD
Dactinomycin—Pancytopenia—Fluorouracil—head and neck cancer	0.000266	0.00346	CcSEcCtD
Dactinomycin—Hepatic failure—Docetaxel—head and neck cancer	0.00026	0.00338	CcSEcCtD
Dactinomycin—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000251	0.00327	CcSEcCtD
Dactinomycin—Pneumonia—Fluorouracil—head and neck cancer	0.000251	0.00326	CcSEcCtD
Dactinomycin—Anaemia—Hydroxyurea—head and neck cancer	0.00025	0.00326	CcSEcCtD
Dactinomycin—Discomfort—Vinblastine—head and neck cancer	0.00025	0.00325	CcSEcCtD
Dactinomycin—Malaise—Hydroxyurea—head and neck cancer	0.000244	0.00318	CcSEcCtD
Dactinomycin—Stomatitis—Fluorouracil—head and neck cancer	0.000243	0.00316	CcSEcCtD
Dactinomycin—Leukopenia—Hydroxyurea—head and neck cancer	0.000242	0.00315	CcSEcCtD
Dactinomycin—Lethargy—Docetaxel—head and neck cancer	0.000238	0.0031	CcSEcCtD
Dactinomycin—Thrombocytopenia—Vinblastine—head and neck cancer	0.000237	0.00309	CcSEcCtD
Dactinomycin—Agranulocytosis—Fluorouracil—head and neck cancer	0.000233	0.00303	CcSEcCtD
Dactinomycin—Anorexia—Vinblastine—head and neck cancer	0.000231	0.00301	CcSEcCtD
Dactinomycin—Discomfort—Hydroxyurea—head and neck cancer	0.000228	0.00296	CcSEcCtD
Dactinomycin—Pharyngitis—Fluorouracil—head and neck cancer	0.000222	0.00289	CcSEcCtD
Dactinomycin—Oedema—Hydroxyurea—head and neck cancer	0.000221	0.00288	CcSEcCtD
Dactinomycin—Infection—Hydroxyurea—head and neck cancer	0.000219	0.00286	CcSEcCtD
Dactinomycin—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000216	0.00282	CcSEcCtD
Dactinomycin—Liver function test abnormal—Docetaxel—head and neck cancer	0.000216	0.00281	CcSEcCtD
Dactinomycin—Anorexia—Hydroxyurea—head and neck cancer	0.000211	0.00274	CcSEcCtD
Dactinomycin—Decreased appetite—Vinblastine—head and neck cancer	0.000211	0.00274	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.00021	0.00274	CcSEcCtD
Dactinomycin—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00021	0.00274	CcSEcCtD
Dactinomycin—Pain—Vinblastine—head and neck cancer	0.000207	0.0027	CcSEcCtD
Dactinomycin—Dysphagia—Docetaxel—head and neck cancer	0.000202	0.00263	CcSEcCtD
Dactinomycin—Feeling abnormal—Vinblastine—head and neck cancer	0.0002	0.0026	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000198	0.00258	CcSEcCtD
Dactinomycin—Alopecia—Fluorouracil—head and neck cancer	0.000198	0.00257	CcSEcCtD
Dactinomycin—Erythema—Fluorouracil—head and neck cancer	0.000195	0.00254	CcSEcCtD
Dactinomycin—Decreased appetite—Hydroxyurea—head and neck cancer	0.000192	0.0025	CcSEcCtD
Dactinomycin—Pancytopenia—Docetaxel—head and neck cancer	0.000192	0.00249	CcSEcCtD
Dactinomycin—Abdominal pain—Vinblastine—head and neck cancer	0.000191	0.00249	CcSEcCtD
Dactinomycin—Fatigue—Hydroxyurea—head and neck cancer	0.00019	0.00248	CcSEcCtD
Dactinomycin—Pain—Hydroxyurea—head and neck cancer	0.000189	0.00246	CcSEcCtD
Dactinomycin—Neutropenia—Docetaxel—head and neck cancer	0.000189	0.00246	CcSEcCtD
Dactinomycin—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000182	0.00237	CcSEcCtD
Dactinomycin—Pneumonia—Docetaxel—head and neck cancer	0.000181	0.00236	CcSEcCtD
Dactinomycin—Anaemia—Fluorouracil—head and neck cancer	0.00018	0.00234	CcSEcCtD
Dactinomycin—Hypersensitivity—Vinblastine—head and neck cancer	0.000178	0.00232	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000178	0.00232	CcSEcCtD
Dactinomycin—Stomatitis—Docetaxel—head and neck cancer	0.000175	0.00228	CcSEcCtD
Dactinomycin—Body temperature increased—Hydroxyurea—head and neck cancer	0.000175	0.00227	CcSEcCtD
Dactinomycin—Leukopenia—Fluorouracil—head and neck cancer	0.000174	0.00227	CcSEcCtD
Dactinomycin—Asthenia—Vinblastine—head and neck cancer	0.000174	0.00226	CcSEcCtD
Dactinomycin—Agranulocytosis—Docetaxel—head and neck cancer	0.000168	0.00219	CcSEcCtD
Dactinomycin—Myalgia—Fluorouracil—head and neck cancer	0.000166	0.00216	CcSEcCtD
Dactinomycin—Diarrhoea—Vinblastine—head and neck cancer	0.000166	0.00216	CcSEcCtD
Dactinomycin—Discomfort—Fluorouracil—head and neck cancer	0.000164	0.00213	CcSEcCtD
Dactinomycin—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000163	0.00212	CcSEcCtD
Dactinomycin—Hepatitis—Docetaxel—head and neck cancer	0.000162	0.0021	CcSEcCtD
Dactinomycin—Pharyngitis—Docetaxel—head and neck cancer	0.00016	0.00209	CcSEcCtD
Dactinomycin—Oedema—Fluorouracil—head and neck cancer	0.000159	0.00207	CcSEcCtD
Dactinomycin—Asthenia—Hydroxyurea—head and neck cancer	0.000158	0.00206	CcSEcCtD
Dactinomycin—Infection—Fluorouracil—head and neck cancer	0.000158	0.00206	CcSEcCtD
Dactinomycin—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000156	0.00203	CcSEcCtD
Dactinomycin—Vomiting—Vinblastine—head and neck cancer	0.000154	0.002	CcSEcCtD
Dactinomycin—Erythema multiforme—Docetaxel—head and neck cancer	0.000153	0.00199	CcSEcCtD
Dactinomycin—Anorexia—Fluorouracil—head and neck cancer	0.000152	0.00197	CcSEcCtD
Dactinomycin—Diarrhoea—Hydroxyurea—head and neck cancer	0.000151	0.00197	CcSEcCtD
Dactinomycin—Flushing—Docetaxel—head and neck cancer	0.00015	0.00195	CcSEcCtD
Dactinomycin—Chills—Docetaxel—head and neck cancer	0.000145	0.00189	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000145	0.00189	CcSEcCtD
Dactinomycin—Nausea—Vinblastine—head and neck cancer	0.000144	0.00187	CcSEcCtD
Dactinomycin—Alopecia—Docetaxel—head and neck cancer	0.000143	0.00186	CcSEcCtD
Dactinomycin—Erythema—Docetaxel—head and neck cancer	0.000141	0.00183	CcSEcCtD
Dactinomycin—Vomiting—Hydroxyurea—head and neck cancer	0.00014	0.00183	CcSEcCtD
Dactinomycin—Rash—Hydroxyurea—head and neck cancer	0.000139	0.00181	CcSEcCtD
Dactinomycin—Decreased appetite—Fluorouracil—head and neck cancer	0.000138	0.0018	CcSEcCtD
Dactinomycin—Pain—Fluorouracil—head and neck cancer	0.000136	0.00177	CcSEcCtD
Dactinomycin—Nausea—Hydroxyurea—head and neck cancer	0.000131	0.00171	CcSEcCtD
Dactinomycin—Feeling abnormal—Fluorouracil—head and neck cancer	0.000131	0.00171	CcSEcCtD
Dactinomycin—Anaemia—Docetaxel—head and neck cancer	0.00013	0.00169	CcSEcCtD
Dactinomycin—Leukopenia—Docetaxel—head and neck cancer	0.000126	0.00164	CcSEcCtD
Dactinomycin—Body temperature increased—Fluorouracil—head and neck cancer	0.000126	0.00164	CcSEcCtD
Dactinomycin—Myalgia—Docetaxel—head and neck cancer	0.00012	0.00156	CcSEcCtD
Dactinomycin—Hypersensitivity—Fluorouracil—head and neck cancer	0.000117	0.00152	CcSEcCtD
Dactinomycin—Oedema—Docetaxel—head and neck cancer	0.000115	0.00149	CcSEcCtD
Dactinomycin—Infection—Docetaxel—head and neck cancer	0.000114	0.00148	CcSEcCtD
Dactinomycin—Thrombocytopenia—Docetaxel—head and neck cancer	0.000112	0.00146	CcSEcCtD
Dactinomycin—Anorexia—Docetaxel—head and neck cancer	0.000109	0.00142	CcSEcCtD
Dactinomycin—Diarrhoea—Fluorouracil—head and neck cancer	0.000109	0.00142	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000105	0.00136	CcSEcCtD
Dactinomycin—Vomiting—Fluorouracil—head and neck cancer	0.000101	0.00132	CcSEcCtD
Dactinomycin—Rash—Fluorouracil—head and neck cancer	0.0001	0.00131	CcSEcCtD
Dactinomycin—Decreased appetite—Docetaxel—head and neck cancer	9.98e-05	0.0013	CcSEcCtD
Dactinomycin—Fatigue—Docetaxel—head and neck cancer	9.89e-05	0.00129	CcSEcCtD
Dactinomycin—Pain—Docetaxel—head and neck cancer	9.81e-05	0.00128	CcSEcCtD
Dactinomycin—Feeling abnormal—Docetaxel—head and neck cancer	9.46e-05	0.00123	CcSEcCtD
Dactinomycin—Nausea—Fluorouracil—head and neck cancer	9.44e-05	0.00123	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Docetaxel—head and neck cancer	9.38e-05	0.00122	CcSEcCtD
Dactinomycin—Body temperature increased—Docetaxel—head and neck cancer	9.07e-05	0.00118	CcSEcCtD
Dactinomycin—Abdominal pain—Docetaxel—head and neck cancer	9.07e-05	0.00118	CcSEcCtD
Dactinomycin—Hypersensitivity—Docetaxel—head and neck cancer	8.46e-05	0.0011	CcSEcCtD
Dactinomycin—Asthenia—Docetaxel—head and neck cancer	8.23e-05	0.00107	CcSEcCtD
Dactinomycin—Diarrhoea—Docetaxel—head and neck cancer	7.85e-05	0.00102	CcSEcCtD
Dactinomycin—Vomiting—Docetaxel—head and neck cancer	7.3e-05	0.00095	CcSEcCtD
Dactinomycin—Rash—Docetaxel—head and neck cancer	7.24e-05	0.000942	CcSEcCtD
Dactinomycin—Nausea—Docetaxel—head and neck cancer	6.82e-05	0.000887	CcSEcCtD
